NeOpuntia® and blood lipid parameters - Scientific substantiation of a health claim related to NeOpuntia® and improvement of blood lipid parameters associated with cardiovascular risk, especially HDL-cholesterol, pursuant to Article 14 of Regulation (EC) No 1924/2006[1] - Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies
Meta data
Keywords
NeOpuntia®, blood lipid, LDL-cholesterol, HDL-cholesterol, cardiovascular risk
Question Number
EFSA-Q-2008-214
Panel members at the time of adoption
Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona
Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Andreu
Palou, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens,
Henk van den Berg, Hendrik van Loveren and Hans Verhagen.
Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Andreu
Palou, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens,
Henk van den Berg, Hendrik van Loveren and Hans Verhagen.
Abstract
No abstract available
© European Food Safety Authority, 2009